Medication leaflets

Active substance

Results for the substance lenvatinib

6 results

About this active substance

Lenvatinib is a medication used to treat certain types of cancer, including thyroid cancer, hepatocellular carcinoma, and renal cancer. It is a tyrosine kinase inhibitor that works by blocking signals that promote tumor growth and the formation of new blood vessels.

The medication is taken orally, usually once daily, and the dosage is adjusted based on body weight and the type of cancer being treated. Treatment is carried out under the supervision of an oncologist.

Side effects may include high blood pressure, fatigue, diarrhea, loss of appetite, and abdominal pain. In rare cases, severe adverse effects such as liver or kidney failure may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the administration instructions. Pregnant or breastfeeding women should not use this medication.